secwatch.observer — SEC 8-K summary
======================================

Issuer:     Axe Compute Inc. (AGPU)
CIK:        0001446159
Form:       8-K
Filed at:   2023-05-15T23:59:59+00:00
Accession:  0001171843-23-003318
Event type: earnings
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Predictive Oncology Q1 2023 net loss $3.4M on revenue $0.2M; partnerships announced
--------------------------------------------------------------------------------

- Net loss of $3.4M, diluted EPS loss $0.86; revenue $239.9K vs $314.6K in Q1 2022.
- Cash $18.6M vs $22.1M at Dec 31, 2022; stockholders' equity $18.6M.
- Gross margin fell to 50% from 65% due to sales mix.
- Partnerships: Cancer Research Horizons, Integra Therapeutics, Cvergenx announced.
- Appointed Veena Rao to Board and Pamela Bush as Chief Business Officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1446159/000117184323003318/0001171843-23-003318-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1446159/000117184323003318/f8k_051523.htm
  HTML page:      https://secwatch.observer/filing/0001171843-23-003318

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer